Biogen
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Biogen and other ETFs, options, and stocks.About BIIB
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis.
BIIB Key Statistics
Stock Snapshot
With a market cap of 37.16B, Biogen(BIIB) trades at $251.36. The stock has a price-to-earnings ratio of 108.57.
As of 2026-11-02, Biogen(BIIB) stock has fluctuated between $251.02 and $255.53. The current price stands at $251.36, placing the stock +0.1% above today's low and -1.6% off the high.
The Biogen(BIIB)'s current trading volume is 139.08K, compared to an average daily volume of 1.4M.
In the last year, Biogen(BIIB) shares hit a 52-week high of $258.78 and a 52-week low of $146.52.
In the last year, Biogen(BIIB) shares hit a 52-week high of $258.78 and a 52-week low of $146.52.
BIIB News
...
Biogen (BIIB) is back in focus after fresh Alzheimer’s data and mixed third quarter figures, as investors weigh revenue growth, continued Leqembi uptake, and th...
Biogen Inc (NASDAQ:BIIB) on Wednesday posted better-than-expected earnings for the third quarter. The company posted adjusted earnings of $2.62 per share, beat...
Analyst ratings
70%
of 37 ratingsMore BIIB News
Biogen Inc. ((BIIB)) has held its Q3 earnings call. Read on for the main highlights of the call. Biogen’s latest earnings call struck a decidedly upbeat tone,...
Biogen reported third quarter 2026 revenue of US$2.80b compared with US$2.53b a year earlier, alongside an adjusted profit of US$2.62 per share that exceeded an...
Biogen (BIIB) shares gained in premarket trading on Wednesday after the Alzheimer's drugmaker reported higher-than-expected Q3 2026 financials thanks mainly to...
Technology Biogen Has 'Returned To Growth,' Says CEO — What To Know About Its Report Licensing Biogen (BIIB) crushed Wall Street's third-quarter expectations ea...
Disclaimer: The TipRanks Smart Score performance is based on backtested results. Backtested performance is not an indicator of future actual results. The result...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.